Psychedelic Guides with Kelsey Ramsden of Mindcure

This week’s Psychedelic Guide is Kelsey Ramsden, President & CEO for Mindcure. MINDCURE is a mental health and wellness company with a mission to identify and develop products that ease suffering, increase productivity, and enhance mental health.

When did you first become involved in the psychedelic industry and why?

As a patient 3 years ago – after exhaustive research into alternate therapy options.

Do you, or have you taken, psychedelic substances?

Yes – I have been a patient of psychedelic-assisted therapy.

What’s your favorite psychedelic compound?

Psilocybin or San Pedro

Do your parents/family members know what you’re doing?


Have you had any experience with mental health/chronic pain?


What’s your vision of the industry in 20 years?

Fully integrated therapy clinics worldwide that include group therapy options. Psychedelic assisted therapy is an option for those who choose it – not only for the classics (depression, PTSD, anxiety etc.) but also for personal growth and performance toward mental wealth. I see digital therapeutics as a backbone of care whereby people engage on an ongoing basis to support their mental wealth with personalized lifestyle integration techniques.

What are your biggest worries for the industry?

Bad actors and bad trips whereby folks un-equipped to address the power of these medicines arrive at outcomes that are not ideal.

Who are your heroes?

My ancestors and those whose shoulders we stand on in this industry.

If you could create a psychedelic to do anything you wanted, what would it do?

Give individuals infinite access to self and compassion for the experience of being human.

We’d like to thank Kelsey for being a part of the Psychedelic Guides series. Stay tuned for weekly profiles on leaders in the psychedelic industry.

Microdose Psychedelic Insights

Microdose Psychedelic Insights

Your Guide to the Business of Psychedelics. Our mission is to shift the world's perception of psychedelic medicine.